PROJECTS
 
LOG IN
SIGN-UP
SEARCH
JUMP TO ADVANCED SEARCH
                                            
Tremendous technological developments in proteomics have occurred in the last few years, primarily through the introduction of novel mass spectrometers.
Welcome to the Genomics Sector Innovation Network (G-SIN) portal

Tremendous technological developments in proteomics have occurred in the last few years, primarily through the introduction of novel mass spectrometers.
EXPLORE >   Projects >  Proteomic Technology for the Study of Rare Cells
Proteomic Technology for the Study of Rare Cells
OBJECTIVES
TEAM
APPROACH
IMPACT
INTELLECTUAL PROPERTY
Objectives
The two-phase development of the proteomic reactor station and the chip proteomic reactor is the brainchild of a group of scientists from the University of Ottawa (Figeys, Wang, and Bennett), the National Research Council (Pezacki and Veres). We are bringing together international expertise in proteomic technology development, microfabrication technologies, and the biology of rare cells.
Project Information
Website
Send a message
Log In to mark favourites


Team
The two-phase development of the proteomic reactor station and the chip proteomic reactor is the brainchild of a group of scientists from the University of Ottawa (Figeys, Wang, and Bennett), the National Research Council (Pezacki and Veres). We are bringing together international expertise in proteomic technology development, microfabrication technologies, and the biology of rare cells.
Collaborator Role In Project Organization Country
Daniel Figeys
Co-Investigator
University of Ottawa
Canada


Approach
We are bringing together international expertise in proteomic technology development, microfabrication technologies, and the biology of rare cells.
Project Information


Impact
Project Information


Intellectual Property

YOU MAY ALSO BE INTERESTED IN:


CATEGORIES
Application Area
Agriculture, Human health
Sign-up to edit this profile
Events Jobs What is Genomics Genomics in Canada About Us Contact Us Privacy Policy Terms of Use Site-Map
© Ontario Genomics Institute, 2007-2013.